Trademark: 97333298
Word
DATISTA PHARMA
Status Date
Friday, May 17, 2024
Filing Date
Monday, March 28, 2022
Published for Opposition
Tuesday, March 28, 2023
5 Medical, biological, and pharmaceutical preparations for treating diabetes for use in connection with humans and animals; Antibiotics, vitamins, and medicated oral and topical pharmaceuticals for treatment of diseases and disorders, namely, for treating diabetes
42 Scientific research and development in the fields of pharmaceuticals, medicine, and biotechnologies
Mar 31, 2022
New Application Entered
Apr 1, 2022
New Application Office Supplied Data Entered
Jan 11, 2023
Assigned To Examiner
Jan 23, 2023
Non-Final Action Written
Jan 23, 2023
Non-Final Action E-Mailed
Jan 23, 2023
Notification Of Non-Final Action E-Mailed
Feb 17, 2023
Teas Response To Office Action Received
Feb 17, 2023
Correspondence Received In Law Office
Feb 18, 2023
Teas/Email Correspondence Entered
Feb 20, 2023
Approved For Pub - Principal Register
Mar 8, 2023
Notification Of Notice Of Publication E-Mailed
Mar 28, 2023
Published For Opposition
Mar 28, 2023
Official Gazette Publication Confirmation E-Mailed
May 23, 2023
Noa E-Mailed - Sou Required From Applicant
Jul 24, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 24, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 24, 2023
Teas Change Of Correspondence Received
May 17, 2024
Sou Extension 2 Granted
May 17, 2024
Sou Extension 2 Filed
May 17, 2024
Sou Teas Extension Received
Aug 17, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 15, 2023
Sou Teas Extension Received
Aug 15, 2023
Sou Extension 1 Filed
Aug 15, 2023
Sou Extension 1 Granted
Trademark Alertz updated from USPTO on 2030-01-24
